Thanks posters above for clarifying. Sounds like it could be more of a distortionary threat then.
It would be a shame for the patient if this initiative redirected investment toward less effective but higher NPAT biotechs with new patents in similar spaces. Gov might need to think it through a bit harder.
General Comments / Chat, page-2855
-
- There are more pages in this discussion • 9,099 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
